Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, closed its $60 million Series D financing...
InSilico Medicine’s $60 Million Series D Financing
PPG’s €1 Billion Notes Offering
K&L Gates advised PPG Industries, while Davis Polk advised the joint book-running managers in the offering. PPG Industries, Inc. executed its offering of €300 million aggregate principal...
Amdocs’ $188 Million Acquisition of MYCOM OSI
Davis Polk advised Amdocs on the deal. Amdocs announced its approximately $188 million acquisition of MYCOM OSI from Inflexion Private Equity and others. The acquisition is...
PT Freeport Indonesia’s $3 Billion Notes Offering
Davis Polk advised PT-FI on the offering. PT-FI issued its three-tranche $3 billion aggregate principal amount of notes offering, which comprises (i) $750 million 4.763% notes due...
JP Morgan Chase’s €2.5 Billion Notes Offering
Davis Polk advised JPMorgan Chase & Co. on the offering. JPMorgan Chase & Co. executed the offering of €2.5 billion aggregate principal amount of its fixed-to-floating-rate notes...
Henkel’s $107 Million Acquisition of Shiseido’s Professional Business
Davis Polk advised Shiseido Company, Limited on the deal. Shiseido Company, Limited announced its transfer of the Professional business, including leading brands such as SUBLIMIC (hair...
Sumitomo Mitsui Financial Group’s $2 Billion Senior Notes Registered Offering
Davis Polk advised Sumitomo Mitsui Financial Group, while Simpson Tacher represented SMBC Nikko Securities America, Inc., Goldman Sachs & Co. LLC, BofA Securities, Inc., Citigroup Global...
Perion Network’s $180 Million Follow-on Public Offering
Davis Polk advised Perion Network Ltd., while Gornitzky represented the underwriters on the deal. Perion Network Ltd. upsized US$180 Million underwritten follow-on public offering of ordinary shares...
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Broncus Holding’s HK$1.55 Billion Initial Public Offering
Davis Polk, Gleiss Lutz and Maples and Calder advised Broncus Holding Corporation, while Dentons Hong Kong advised Goldman Sachs and Haitong International Capital in the transaction....
Sumitomo Mitsui Financial Group’s $850 Million Subordinated Notes Offering
Davis Polk advised Sumitomo Mitsui Financial Group, Inc. on the offering. Sumitomo Mitsui Financial Group executed its $850 million SEC-registered takedown offering of 2.930% subordinated notes due...
Sumitomo Mitsui Financial Group’s $5 Billion Senior Notes Offering
Davis Polk advised Sumitomo Mitsui Financial Group on the deal. Sumitomo Mitsui Financial Group, Inc. executed its SEC-registered takedown offering of senior total loss-absorbing capacity (“TLAC”)...